• ÎÄÏ×·ÖÏí|NKbjlƽ̨ÍâÃÚbjlƽ̨¹ÙÍøµÄDZÔÚÓ¦ÓÃ

    ÈÕÆÚ£º01-22  µã»÷£º  ÊôÓÚ£ºÎÄÏ×·ÖÏí

     

     

     

    ÎÄ

    Ï×

    ·Ö

    Ïí

     

    ÍâÃÚbjlƽ̨¹ÙÍøÊǾßÓÐÁ×֬˫²ãĤ½á¹¹µÄÄÒÅÝ£¬ÓɶàÖÖbjlƽ̨Ö÷¶¯·ÖÃÚ²¢Ð¯´øÆäÔ´bjlƽ̨µÄÌØÕ÷ÎïÖÊ¡£ÍâÃÚbjlƽ̨¹ÙÍø±»ÈÏΪÊÇÒ»ÖÖbjlƽ̨¼äÏ໥×÷ÓòúÉú¸÷ÖÖÉúÎïЧӦµÄÐÂÐÍÊֶΣ¬ÆäÖÐNKbjlƽ̨ÍâÃÚbjlƽ̨¹ÙÍøº¬ÓжàÖÖÓÕµ¼°Ðbjlƽ̨ËÀÍöµÄÁѽâ¿ÅÁ££¨´©¿×ËØ¡¢¿ÅÁ£Ã¸£©¡¢bjlƽ̨Òò×Ó£¨TNF-α¡¢IL-10¡¢IFN-㣩¡¢Ç÷»¯Òò×Ó£¨CCL3¡¢CCL4¡¢CCL5£©ºÍÉú³¤Òò×Ó£¨GM-CSF£©£¬¿ÉÒÔÖ±½Ó»ò¼ä½ÓµØ·¢»Ó¿¹Ö×ÁöЧ¹û¶ø±¸ÊܹØ×¢¡£ÉîÛÚbjlƽ̨¹ÈÖÆ±¸µÄNKbjlƽ̨ÍâÃÚbjlƽ̨¹ÙÍøÒÑÔÚbjlƽ̨¹ÙÍøÍâÖ¤Ã÷³Ê¼ÁÁ¿ÒÀÀµÐÔ·¢»Ó¿¹Ö×Áö»îÐÔ¡£³ý´ËÖ®Í⣬NKbjlƽ̨ÍâÃÚbjlƽ̨¹ÙÍøÔÚÖÎÁÆÌÇÄò²¡ºÍƤ·ô²¡ÉÏÒ²¾ßÓÐDZÔÚµÄÓ¦ÓüÛÖµ¡£

    ¢òÐÍÌÇÄò²¡£¨T2D£©ÊÇ´úлÐÔÌÇÄò²¡×î³£¼ûµÄÐÎʽ£¬ÆäÌØÕ÷ÊǸßѪÌÇ£¨Ò²³ÆÎª¸ßѪÌÇÖ¢£©ºÍÒȵºËصֿ¹¡£ÒȵºËصֿ¹µÄÖ¢×´°üÀ¨Ö¬·¾bjlƽ̨¡¢¼¡Èâbjlƽ̨ºÍ¸Îbjlƽ̨¶ÔÒȵºËصÄÃô¸ÐÐÔ½µµÍ£¬ÒÔ¼°ÒȵºËØÐźÅʧµ÷ºÍÆÏÌÑÌÇ¡¢Ö¬·¾ºÍµ°°×ÖÊ´úлÎÉÂÒ£¬×îÖÕµ¼ÖÂT2DµÄ²¢ÐÐÉÏÉý¡£ÒÑÓÐÑо¿±íÃ÷£¬¸÷ÖÖÃâÒßbjlƽ̨£¬ÈçTbjlƽ̨¡¢Bbjlƽ̨¡¢¾ÞÊÉbjlƽ̨ºÍNKbjlƽ̨£¬ÔÚT2DÖз¢»Ó×ÅÖÁ¹ØÖØÒªµÄ×÷Ó᣷¢±íÔÚ¡¶Signal Transduction and Targeted Therapy¡·µÄһƪÎÄÏ×Öз¢ÏÖ£¬À´×ÔÊÝСÊóµÄNKbjlƽ̨ÑÜÉúµÄÍâÃÚbjlƽ̨¹ÙÍøÄܹ»¼õÇá·ÊÅÖÓÕµ¼µÄ¢òÐÍÌÇÄò²¡Ð¡ÊóÄ£ÐÍÖеÄÒȵºËصֿ¹ºÍÑ×Ö¢¡£

    ÊÝСÊóNKbjlƽ̨ÑÜÉúµÄÍâÃÚbjlƽ̨¹ÙÍøÔöÇ¿ÁËÖ¬·¾bjlƽ̨ºÍ¸Îbjlƽ̨µÄÒȵºËØÃô¸ÐÐÔ£¬²¢¼õÇáÁËÑ×Ö¢¡£ÔÚÊÝСÊóNKbjlƽ̨ÑÜÉúµÄÍâÃÚbjlƽ̨¹ÙÍøÖУ¬miR-1249-3pÏÔÖøÉϵ÷£¬²¢ÇÒ¿ÉÒÔͨ¹ýÍâÃÚbjlƽ̨¹ÙÍø´ÓNKbjlÆ½Ì¨×ªÒÆµ½Ö¬·¾bjlƽ̨ºÍ¸Îbjlƽ̨¡£NKbjlƽ̨ÑÜÉúµÄÍâÃÚbjlƽ̨¹ÙÍømiR-1249-3pÏÔÖøÓÕµ¼ÒȵºËØÃô¸ÐÐÔ²¢¼õÇáÑ×Ö¢¡£´Ó»úÖÆÉϽ²£¬ÍâÃÚbjlƽ̨¹ÙÍømiR-1249-3pÖ±½Ó°ÐÏòSKOR1£¬²¢µ÷½ÚSMAD6/MYD88/SMURF1ÈýÔª¸´ºÏbjlƽ̨¹ÙÍøµÄÐγÉ£¬¸Ã¸´ºÏbjlƽ̨¹ÙÍøÄܹ»Í¨¹ýÒÖÖÆTLR4/NF-κBÐźÅͨ·½éµ¼ÆÏÌÑÌÇÎÈ̬¡£¸ÃÑо¿½ÒʾÁËNKbjlƽ̨ÑÜÉúµÄÍâÃÚbjlƽ̨¹ÙÍømiR-1249-3pÔÚ»º½âÒȵºËصֿ¹ÖеÄÐÂ×÷Ó㬲¢ÎªT2DÌṩÁËһϵÁÐDZÔÚµÄÖÎÁưеã[1]¡£

    ³ýÁ˸ßѪÌǵ¼ÖµÄѪҺѭ»·Õϰ­¡¢Ï¸¾ú×ÌÉúºÍÃâÒßÁ¦Ï½µÖ®Í⣬ÌÇÄò²¡»¼Õß»¹³£³£ÔâÓöÉË¿ÚÓúºÏ»ºÂýµÄÎÊÌâ¡£ÔÚ¡¶Diabetes Research and Clinical Practice¡·ÔÓÖ¾ÉÏ·¢±íµÄÒ»ÏîÑо¿ÉîÈë̽ÌÖÁËÍâÃÚbjlƽ̨¹ÙÍøÔÚ´Ù½øÌÇÄò²¡ÉË¿ÚÓúºÏ¹ý³ÌÖеĹؼü×÷Ó㬰üÀ¨ÆäÔÚѪ¹ÜÉú³É¡¢½ºÔ­ºÏ³ÉºÍÑ×Ö¢ÒÖÖÆ·½ÃæµÄDZÔÚÓ¦Ó᣸ÃÎÄÏ×Ïêϸ²ûÊöÁËÍâÃÚbjlƽ̨¹ÙÍøÈçºÎͨ¹ýµ÷½ÚÌØ¶¨¹¦ÄÜ·Ö×ӵıí´ï£¬Ó°ÏìÄÚÆ¤bjlƽ̨£¨ECs)¡¢³ÉÏËάbjlƽ̨¡¢¾ÞÊÉbjlƽ̨ºÍ½ÇÖÊÐγÉbjlƽ̨µÈ¹Ø¼übjlƽ̨ÀàÐÍ£¬½ø¶øÍƶ¯ÌÇÄò²¡É˿ڵÄÓúºÏ½ø³Ì¡£´ËÍ⣬ÍâÃÚbjlƽ̨¹ÙÍøÔÚbjlƽ̨¼äͨÐÅÖеÄ×÷ÓÃÒ²²»ÈݺöÊÓ£¬ËüÃÇÄܹ»Ð¯´øµ°°×ÖÊ¡¢Ö¬ÖÊ¡¢RNAºÍDNAµÈÐÅÏ¢»õÎʵÏÖbjlƽ̨¼äµÄÐÅÏ¢½»Á÷¡£ÖµµÃ×¢ÒâµÄÊÇ£¬ÌÇÄò²¡ÉË¿ÚµÄÆ¤·ô×éÖ¯ÍùÍù³ÐÊÜןüΪÑÏÖØµÄÑõ»¯Ó¦¼¤£¬ÕâÖÖ¸ßÑõ»¯Ó¦¼¤×´Ì¬¿ÉÄܵ¼ÖÂbjlƽ̨Äڵĵ°°×ÖÊ¡¢Ö¬ÖʺÍDNAÊÜËð£¬ÒýÆðbjlƽ̨ËÀÍöºÍ×éÖ¯¹¦ÄÜÕϰ­ £¬×îÖÕÓ°ÏìÉ˿ڵÄÓúºÏ¡£ÍâÃÚbjlƽ̨¹ÙÍøÍ¨¹ý½µµÍÑõ»¯Ó¦¼¤Ë®Æ½£¬·¢»ÓÁË»ý¼«×÷Óá£ÌرðÊÇÄÇЩ¹ý±í´ïºËÒò×Ó-E2Ïà¹ØÒò×Ó2£¨Nrf2£©µÄADSCÑÜÉúÍâÃÚbjlƽ̨¹ÙÍø£¬Òѱ»Ö¤ÊµÄܹ»¼õÉÙÑ×Ö¢ºÍÑõ»¯Ó¦¼¤Ïà¹Øµ°°×µÄ±í´ïˮƽ£¬²¢ÓÐЧ´Ù½øÁËÌÇÄò²¡´óÊóÄ£ÐÍÖеÄÉË¿ÚÓúºÏ¡£Õâ±íÃ÷ÍâÃÚbjlƽ̨¹ÙÍø²»½öÄÜÒÖÖÆ¹ý¶ÈÑ×Ö¢µÄ·¢Éú£¬±ÜÃâÆä¶ÔÉË¿ÚÓúºÏµÄ²»ÀûÓ°Ï죬¶øÇÒ»¹ÄÜͨ¹ý¶àÖÖ»úÖÆÏÔÖø´Ù½øÌÇÄò²¡ÐÔÉ˿ڵÄÓúºÏ¹ý³Ì¡£ÕâЩ·¢ÏÖΪÌÇÄò²¡ÉË¿ÚÖÎÁÆÌṩÁËеIJßÂÔºÍDZÔÚµÄÖÎÁưеã[2]¡£

    ³ýÁËÔÚ¢òÐÍÌÇÄò²¡ÖеÄDZÔÚ×÷Óã¬NKbjlƽ̨ÔÚÆ¤·ô²¡ÖÎÁÆÁìÓòÒ²ÏÔʾ³öÁ˾޴óµÄÖÎÁÆÇ±Á¦¡£ÔÚ¡¶Science Translational Medicine¡·ÔÓÖ¾ÉÏ·¢±íµÄһƪÑо¿ÎÄÏ×ÖУ¬Ì½ÌÖÁËÌØÓ¦ÐÔÆ¤Ñ×£¨Atopic Dermatitis£¬AD£©ÓëNKbjlƽ̨ȱÏÝÖ®¼äµÄ¹ØÁª£¬²¢Ñ°ÇóÁËÒ»ÖÖ¿ÉÄܵÄÃâÒßÖÎÁÆÐ²ßÂÔ¡£Ñо¿ÕßÃÇ·¢ÏÖ£¬AD»¼ÕßµÄѪҺÖÐNKbjlƽ̨µÄÊýÁ¿ÓÐËù¼õÉÙ£¬¶øÇÒÕâÖÖ¼õÉÙËæ×ÅÖÎÁƵĽøÐжøµÃµ½¸ÄÉÆ¡£Í¨¹ýÔËÓöàάµ°°×ÖʺÍRNA·ÖÎö¼¼Êõ£¬Ñо¿ÕßÃǹ۲쵽ÓëNKbjlƽ̨ËÀÍöÔöÇ¿Ïà¹ØµÄÑÇȺˮƽ±ä»¯¡£ÔÚСÊóÄ£ÐÍÖУ¬NKbjlƽ̨µÄȱ·¦ÓëÆ¤·ôÖÐ2ÐÍÑ×Ö¢µÄ¼Ó¾çÓйأ¬ÕⰵʾÁËNKbjlƽ̨ÔÚµ÷½ÚÃâÒß·´Ó¦ÖеĹؼü×÷Ó᣻ùÓÚÕâÐ©ÖØÒª·¢ÏÖ£¬Ñо¿ÍŶÓÀûÓÃÒ»ÖÖÄܹ»ÔöÇ¿NKbjlƽ̨»îÐԵİ×bjlƽ̨½éËØ-15£¨IL-15£©³¬¼¤¶¯¼Á½øÐÐÖÎÁÆ£¬½á¹û·¢ÏÖСÊóµÄADÑù¼²²¡µÃµ½ÁËÏÔÖøµÄ¸ÄÉÆ¡£ÕâÐ©Í»ÆÆÐԵķ¢ÏÖ½ÒʾÁËIL-15³¬¼¤¶¯¼ÁÔÚ°©Ö¢ÃâÒßÖÎÁÆÁìÓòÖ®ÍâµÄÁíÒ»ÖÖDZÔÚÓ¦Ó㬼´×÷ΪһÖÖеÄADÃâÒßÖÎÁƲßÂÔ[3]¡£

    ´ËÍ⣬NKbjlƽ̨ÅàÑø»ùÔÚÒ©×±ÁìÓòÒ²Õ¹ÏÖ³öÁËÏ൱µÄÓ¦ÓÃDZÁ¦¡£ÔÚ¡¶Journal of Cosmetics, Dermatological Sciences and Applications¡·ÉÏ·¢±íµÄÒ»ÏîÑо¿ÖУ¬¿ÆÑ§¼ÒÃÇ̽¾¿Á˸»º¬NKbjlƽ̨µÄÁܰÍbjlƽ̨ÅàÑø»ùÔÚÆ¤·ô»¤Àí·½ÃæµÄÓ¦ÓÃǰ¾°£¬ÓÈÆäÊÇÔÚ»¯×±Æ·³É·ÖµÄ¿ª·¢ÉÏ¡£¸ÃÅàÑø»ùÖÐÔ̺¬µÄ¶àÖÖbjlƽ̨Òò×ÓÄܹ»Í¨¹ý´Ù½øKLKs£¨¼¤ëÄÊÍ·Åø£©µÄÔö¼ÓºÍ¼õÉÙ½ðÊôµ°°×øMMP-1ÓëMMP-2µÄ±í´ïÀ´ÔöÇ¿ÉË¿ÚÓúºÏÄÜÁ¦£¬½ø¶øÓÐЧÒÖÖÆÖåÎÆµÄÐγÉ¡£Ñо¿½á¹ûÏÔʾ£¬¸»º¬NKbjlƽ̨µÄÁܰÍbjlƽ̨ÅàÑø»ùͨ¹ý¼¤»îHaCaT½ÇÖÊÐγÉbjlƽ̨µÄÇ¨ÒÆ£¬²»½öÌáÉýÁËbjlÆ½Ì¨Ç¨ÒÆÄÜÁ¦£¬»¹Éϵ÷ÁËKLKsµÄ±í´ï£¬²¢Ïµ÷ÁËMMP-1ºÍMMP-2µÄˮƽ¡£Òò´Ë£¬¸ÃÖÖÅàÑø»ù×÷ΪһÖÖ»¯×±Æ·³É·Ö£¬¾ßÓдٽøÆ¤·ôÔÙÉúºÍ¿¹Ë¥ÀϵÄË«ÖØ¹¦Ð§[4]¡£

    ½ØÖÁĿǰ£¬NKbjlƽ̨¼°ÆäÍâÃÚbjlƽ̨¹ÙÍøÔÚ¶à¸öÁìÓòÕ¹ÏÖ³öÁËÁîÈËÖõÄ¿µÄDZÁ¦£¬È»¶øÄ¿Ç°µÄÑо¿´ó¶à»¹Í£ÁôÔÚ¶¯ÎïÄ£Ðͽ׶Ρ£ÈôÒª½«ÕâЩÑо¿³É¹ûת»¯ÎªÁÙ´²Êµ¼ù£¬Î´À´ÐèÒª¿ªÕ¹¸ü¶àµÄÁÙ´²ÊÔÑéÀ´ÑéÖ¤ÆäÁÆÐ§ºÍ°²È«ÐÔ¡£ÁíÒ»·½Ã棬ÔÚ×ßÏòÁÙ´²Ó¦ÓÃ֮ǰ£¬»¹Ðè½â¾öһϵÁбê×¼»¯ÎÊÌ⣬°üÀ¨ÖƱ¸¹ý³ÌµÄÖÊÁ¿¿ØÖÆ¡¢ÖÎÁƼÁÁ¿µÄÈ·¶¨ÒÔ¼°ÁÆÐ§ÆÀ¹ÀµÄ±ê×¼»¯µÈ¡£ÕâЩ±ê×¼»¯¹¤×÷¶ÔÓÚÈ·±£ÖÎÁƵÄÒ»ÖÂÐԺͿɿ¿ÐÔÖÁ¹ØÖØÒª¡£×ܶøÑÔÖ®£¬Æ¾½èÆä¶ÀÌØµÄÉúÎïÑ§ÌØÐÔºÍÏÔÖøµÄ¿¹Ö×Áö»îÐÔ£¬NKbjlƽ̨¼°ÆäÍâÃÚbjlƽ̨¹ÙÍøÓÐDZÁ¦³ÉΪ¶àÖÖ¼²²¡ÃâÒßÖÎÁÆ»òÃÀÈÝ¿¹Ë¥µÄÐÂÑ¡Ôñ¡£»¶Ó­¸ÐÐËȤ¶ÁÕßÁªÏµÉîÛÚbjlƽ̨¹ÈºÏ×÷½»Á÷¡£

     

    ²Î¿¼ÎÄÏ×£º

    [1] Wang, Y., Li, M., Chen, L. et al. Natural killer cell-derived exosomal miR-1249-3p attenuates insulin resistance and inflammation in mouse models of type 2 diabetes. Sig Transduct Target Ther 6, 409 (2021).

    [2] Li D, Wu N. Mechanism and application of exosomes in the wound healing

    process in diabetes mellitus. Diabetes Res Clin Pract. 2022 May;187:109882.

    [3] Mack MR, Brestoff JR, Berrien-Elliott MM, Trier AM, Yang TB, McCullen M,

    Collins PL, Niu H, Bodet ND, Wagner JA, Park E, Xu AZ, Wang F, Chibnall R,

    Council ML, Heffington C, Kreisel F, Margolis DJ, Sheinbein D, Lovato P, Vivier E,

    Cella M, Colonna M, Yokoyama WM, Oltz EM, Fehniger TA, Kim BS. Blood natural

    killer cell deficiency reveals an immunotherapy strategy for atopic dermatitis. Sci

    Transl Med. 2020 Feb 26;12(532):eaay1005.

    [4] "Potential of Natural Killer Cell Enriched Conditioned Media for Skin Care and

    Anti-Aging" written by Dong Soo Kim, Dong Ju Kim, Hyun Pyo Kim, Sung Hwan

    Hwang, Jung Hwa Kang, published by Journal of Cosmetics, Dermatological

    Sciences and Applications, Vol.11 No.2, 2021

     

    ÃâÔðÉùÃ÷£ºÉîÛÚbjlƽ̨¹ÈÖÂÁ¦ÓÚÑо¿bjlƽ̨Óë»ùÒòÁÆ·¨£¬ÎªÍƶ¯ÐÂÐ˼¼Êõ£¬Èøü¶àÈËÁ˽âÉúÎïbjlƽ̨¹ÙÍøÒ©Ð·¢Õ¹¡£±¾ÎÄÄÚÈݽö×÷ÐÅÏ¢½»Á÷ʹÓ㬱¾Æ½Ì¨¶ÔÎÄÖÐÄÚÈÝ¡¢³ÂÊö¡¢¹ÛµãÅжϱ£³ÖÖÐÁ¢£¬²»´ú±íÉîÛÚbjlƽ̨¹ÈÁ¢³¡ºÍ¹Ûµã¡£±¾ÎÄÏà¹ØÐÅÏ¢²»µÃÓÃ×÷Õï¶Ï»òÖÎÁÆ£¬²»ÄÜ´úÌæ×¨bjlƽ̨¹ÙÍøbjlƽ̨¹ÙÍøÑ§Òâ¼û£¬±¾¹«ÖÚÆ½Ì¨½«²»³Ðµ£ÈκÎÔðÈΡ£ÒÔÉÏÉùÃ÷ÄÚÈݵÄ×îÖÕ½âÊÍȨ¹é±¾¹«ÖÚÆ½Ì¨ËùÓУ¬±¾ÉùÃ÷½«ÊÊÓñ¾Æ½Ì¨ËùÓÐʱ¼ä·ÖÏíµÄÎÄÕ£¬Ð»Ð»ºÏ×÷£¡

    °æÈ¨ËµÃ÷£ºÎÄÕ°æÈ¨¹éÉîÛÚbjlƽ̨¹ÈËùÓУ¬»¶Ó­¸öÈËת·¢ÖÁÅóÓÑȦ£¬Ã½bjlƽ̨¹ÙÍø»ò»ú¹¹ÔÚδ¾­ÊÚȨÏ£¬ÒÔÈκÎÐÎÊ½×ªÔØµ½ÆäËûƽ̨£¬½«ÊÓΪÇÖȨ¡£×ªÔØÊÚȨÇëÔÚ¡¸ÉîÛÚbjlƽ̨¹È¡¹Î¢ÐŹ«ÖںŻظ´“×ªÔØ”£¬»ñÈ¡×ªÔØÐëÖª¡£

     

    ÍùÆÚÍÆ¼ö  //

     

    ÎÄÏ×·ÖÏí|NKbjlƽ̨ÃâÒß¼àÊÓÔÚÖ×Áö×ªÒÆÖз¢»Ó¹Ø¼ü×÷ÓÃ

    ÎÄÏ×·ÖÏí| Cell£ºÍ¨ÓÃÐÍCAR-Tbjlƽ̨ÔÚ×ÔÉíÃâÒßÐÔ¼²²¡ÉϵÄÊ״γɹ¦Ó¦ÓÃ

    ÎÄÏ×·ÖÏí|Ç÷»¯Òò×ÓÍøÂçµ÷½ÚNKbjlÆ½Ì¨Ç¨ÒÆºÍ½þÈóÖÁʵbjlƽ̨¹ÙÍøÁö

    ÎÄÏ×·ÖÏí|ʱ¼ä½ÚÂÉ——Ó°Ïìbjlƽ̨ÖÎÁÆÁÆÐ§µÄÒòËØÖ®Ò»

    ¹ØÓÚÉîÛÚbjlƽ̨¹È

    ÉîÛÚbjlƽ̨¹ÈÉúÎïbjlƽ̨¹ÙÍøÒ©ÓÐÏÞ¹«Ë¾£¨Ï³Æ:ÉîÛÚbjlƽ̨¹È£©ÊǹúÄÚΨһһ¼Ò¿ÉÌṩ¹¤bjlƽ̨¹ÙÍø¼¶Äæ×ªÂ¼²¡¶¾ÔØbjlƽ̨¹ÙÍøµÄbjlƽ̨Óë»ùÒòÖÎÁÆÒ»Õ¾Ê½½â¾ö·½°¸·þÎñÉÌ£¬ÓÉÀ´×ÔÃÀ¹ú¹þ·ð´óѧºÍ¼ÓÖÝ´óѧʥµü¸ê·ÖУµÈº£¹é¿ÆÑ§¼ÒÁªºÏ´´°ì£¬ÓµÓйúÄÚÊ×ÅúÕÆÎÕ¹¤bjlƽ̨¹ÙÍø¼¶Äæ×ªÂ¼²¡¶¾ÔØbjlƽ̨¹ÙÍø¼¼Êõ£¨PackRV-SSϵͳ£©µÄÑз¢Éú²úÍŶÓ¡£ÉîÛÚbjlƽ̨¹ÈÒѽ¨³É¹æ·¶»¯£¬±ê×¼»¯£¬¹¤bjlƽ̨¹ÙÍø»¯Éú²úGMP¼¶Äæ×ªÂ¼²¡¶¾ÔØbjlƽ̨¹ÙÍø¼°CAR-TµÈbjlƽ̨²úÆ·¹ÜÏߣ¬ÒÑÔÚÉîÛÚ¡¢±±¾©ºÍÖÐɽÈýµØ½¨Á¢²úbjlƽ̨¹ÙÍøÁª¶¯£¬½¨³É¹²¼Æ³¬Íòƽ·ûºÏ¹ú¼ÊGMP±ê×¼µÄÉú²ú³µ¼ä¼°Ñз¢ÊµÑéÊÒ¡£ÉîÛÚbjlƽ̨¹È´Ó²¡¶¾ÔØbjlƽ̨¹ÙÍø¹ÜÏߣ¬µ½bjlƽ̨²úÆ·¹ÜÏߣ¬ÔÙµ½IIT/IND/NDA¸¨ÖúÉ걨£¬ÔÙµ½ÐÐbjlƽ̨¹ÙÍøÄÚÈ˲ÅÅàÑøÒѽ¨Á¢³ÉÊìµÄÈ«Á÷³Ì¡¢Ò»Õ¾Ê½Î¯ÍзþÎñ£¬½¨ÓÐÄæ×ªÂ¼²¡¶¾¡¢Âý²¡¶¾µÈ¶àÖÖ²¡¶¾ÔØbjlƽ̨¹ÙÍøÉú²ú¹ÜÏß¼°CAR-T¡¢CAR-NK¡¢TCR-TµÈbjlƽ̨Éú²ú¹ÜÏß¡£Í¬Ê±ÓëÉóÆÀ¼ìÑé»ú¹¹¡¢¿ÆÑÐÔºËù¡¢bjlƽ̨¹ÙÍøÔººÍÐÐbjlƽ̨¹ÙÍøÁúÍ·Æóbjlƽ̨¹ÙÍøÉî¶ÈºÏ×÷£¬ÌṩIIT¡¢IND¸¨ÖúÉ걨·þÎñ¡£

    ÉîÛÚbjlƽ̨¹ÈÊÇÉîÛÚÊÐÉúÎïbjlƽ̨¹ÙÍøÒ©²úbjlƽ̨¹ÙÍøÖØ´ó¹«¹²·þÎñƽ̨¡¢ÉîÛÚÊÐÖØ´óÏîÄ¿¡¢ÉîÛÚÊиßÐÂÇø·¢Õ¹×¨Ïî¼Æ»®´´ÐÂÆ½Ì¨³É¹û²úbjlƽ̨¹ÙÍø»¯»ùµØ¡¢“¾ÛÁúÁì¾üÈ˲ŔDÀà¸ß³É³¤ÐÔÆóbjlƽ̨¹ÙÍø¡¢bjlƽ̨²úbjlƽ̨¹ÙÍø¹Ø¼ü¹²ÐÔ¼¼Êõ¹ú¼Ò¹¤³ÌÑо¿ÖÐÐIJ¡¶¾ÔØbjlƽ̨¹ÙÍø¹²ÐÔ¼¼ÊõÑо¿Æ½Ì¨¡¢ÖйúʳƷҩƷÆóbjlƽ̨¹ÙÍøÖÊÁ¿°²È«´Ù½ø»á¸±»á³¤µ¥Î»¡¢ÉîÛÚÊÐbjlƽ̨¹ÙÍøÑ§Ñо¿×¨Ïî×ʽðÒÀÍе¥Î»¡¢ÉîÛÚÊÐÉúÎïbjlƽ̨¹ÙÍøÒ©²ú½ÌÁªÃ˸±Àíʳ¤µ¥Î»¡¢È«¹úÉúÎï¼¼ÊõÐÐbjlƽ̨¹ÙÍø²ú½ÌÈںϹ²Í¬bjlƽ̨¹ÙÍø³£ÎñÀíʵ¥Î»¡¢ÉîÛÚÊÐÉúÎïbjlƽ̨¹ÙÍøÒ©´Ù½ø»áÀíʵ¥Î»¡¢2022Äê¶ÈÆºÉ½Çø“Ê®´ó´´ÐÂÆ½Ì¨”¡¢¿Æ¼¼ÐÍÖÐСÆóbjlƽ̨¹ÙÍø¡¢´´ÐÂÐÍÖÐСÆóbjlƽ̨¹ÙÍø¡¢ÉîÛÚÊÐÆºÉ½Çø´óѧÉúʵϰ»ùµØ£¬ÈÙ»ñ2024Äê¶ÈÑÇÌ«Çøbjlƽ̨Óë»ùÒòÖÎÁÆÐÐbjlƽ̨¹ÙÍøÖ®ÐÇ“×î¼Ñ¼¼ÊõÍ»ÆÆ½±”¡¢µÚÊ®¶þ½ìÖйú´´Ð´´bjlƽ̨¹ÙÍø´óÈüÓÅÐãÆóbjlƽ̨¹ÙÍø½±¡¢Öйú´´½»»á´´Ð´´bjlƽ̨¹ÙÍø´óÈüÈýµÈ½±¡¢CGTÁìÓòCDMOºÏ×÷ÆôÃ÷Ðǽ±¡£

    ×óÓÒ»¬¶¯¿Éä¯ÀÀ¸ü¶àͼƬ

     

    END

     

    ΢ÐŹ«ÖÚºÅ

    Êг¡²¿£ºËïŮʿ

    bjlƽ̨»ÝÖÚÉú »ùÒò´´Î´À´

    È«¹úͳһ·þÎñÈÈÏß

    400-800-1266

     Á˽â¸ü¶àÄÚÈÝÇëµÇ¼  

    www.sz-cell.com

    ΢ÐŹ«ÖÚºÅ
    ɨһɨ£¬¹Ø×¢ÎÒÃÇ×îÐÂÏûϢɨһɨ£¬¹Ø×¢ÎÒÃÇ×îÐÂÏûÏ¢
    ÁªÏµÎÒÃÇ
    400-800-1266

    ¹¤×÷ʱ¼ä£ºÖÜÒ»ÖÁÖÜÎå 9:00-18:00

    ÁªÏµÈË£ºÀµÅ®Ê¿

    ÊÖ»ú£º13670105633

    Óʼþ£ºlaijiaqi@sz-cell.com

    µØÖ·£ºÉîÛÚÊÐÆºÉ½Çø¿Óè÷½ÖµÀ½ðɳÉçÇøÈÙÌï·1ºÅº£ÆÕÈðÉúÎïbjlƽ̨¹ÙÍøÒ©Éú̬԰

    µ×²¿µ¼º½
    ÉîÛÚbjlƽ̨¹ÈÉúÎïbjlƽ̨¹ÙÍøÒ©ÓÐÏÞ¹«Ë¾ÊÇÖйúÒ»¼ÒרעÓÚbjlƽ̨ºÍ»ùÒòÖÎÁƲúbjlƽ̨¹ÙÍøÁìÓòµÄһվʽ×ÛºÏÍâ°ü·þÎñÉÌ£¬Ò²ÊǹúÄÚÊ×Åú¾ß±¸ÁÙ´²¼¶Ä没¶¾ÔØbjlƽ̨¹ÙÍøGMP¹¤bjlƽ̨¹ÙÍø»¯Éú²úµÄCRO/CDMO¹«Ë¾¡£ ÉîÛÚbjlƽ̨¹ÈÊÇÉîÛÚÊÐÖØ´óCRO/CDMO¹«¹²¼¼Êõ·þÎñƽ̨½¨ÉèÏîÄ¿£¬Ò²ÊÇÉîÛÚÊÐ×îй«²¼µÄ20+8Õ½ÂÔÐÔÐÂÐ˲úbjlƽ̨¹ÙÍøÏîÄ¿¡£ÉîÛÚbjlƽ̨¹È¾ßÓй淶»¯£¬±ê×¼»¯£¬¹¤bjlƽ̨¹ÙÍø»¯Éú²úGMP¼¶CAR-TµÈbjlƽ̨²úÆ·µÄÄÜÁ¦£¬Ö÷Òª½¨ÓÐCAR-T¡¢CAR-NK¡¢CAR-M¡¢¦Ã¦ÄT¡¢TIL¡¢TCR-TµÈbjlƽ̨²úÆ·Éú²úÏߣ¬Ä没¶¾¡¢Âý²¡¶¾¡¢·Ç²¡¶¾ÔØbjlƽ̨¹ÙÍø¡¢AAVµÈ¶àÖÖ²¡¶¾ÔØbjlƽ̨¹ÙÍøÒÔ¼°ÍâÃÚbjlƽ̨¹ÙÍø¡¢»ùÒò¹¤³Ì¿¹bjlƽ̨¹ÙÍø¡¢bjlƽ̨Òò×Ó¡¢ÈÜÁö²¡¶¾¡¢ÒßÃçµÈÒ©Æ·Éú²úµÄbjlƽ̨ԭÁϲúÆ·Éú²úÏß¡£
    ÉîÛÚbjlƽ̨¹ÈÉúÎïbjlƽ̨¹ÙÍøÒ©ÓÐÏÞ¹«Ë¾ °æÈ¨ËùÓРÔÁICP±¸2024168379ºÅ »¥ÁªÍøÒ©Æ·ÐÅÏ¢·þÎñ×ʸñÖ¤Ê飺(ÔÁ)-·Ç¾­ÓªÐÔ-2022-0426  ¼¼ÊõÖ§³Ö£ºÓѵãÈí¼þ
    ¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿